Bariatric surgery, often known as weight loss surgery, is a type of bariatric surgery that involves a minimally invasive surgical treatment to treat obesity. The goal of bariatric surgery is to help people lose weight by reducing the size of their stomach by removing a portion of the stomach's tissues or fats. Depending on a person's BMI, the National Institutes of Health in the United States recommends bariatric surgery. Individuals with a BMI of 40 or less are suggested for bariatric surgery; however, patients with specific major comorbid medical conditions such as diabetes can have bariatric surgery with a BMI of 35.
The figures show that worldwide obesity has tripled since 1975, according to the World Health Organization. According to the primary statistics, over 1.9 billion adults were overweight in 2016, with 650 million of them being obese. This tendency was reported to continue even in children under the age of five, with 40 million youngsters being overweight in 2018. This has primarily boosted the number of people undergoing bariatric surgery, fueling the expansion of the bariatric surgery devices market. Furthermore, people's precautionary and preventive actions have resulted in an increase in overall expenditure on weight loss, which supports global sales of bariatric surgical devices.
Market Dynamics for Bariatric Surgery Devices Worldwide
The Immune Checkpoint Inhibitors Market is predicted to develop due to factors such as rising obesity prevalence. According to the World Health Organization, 39.0 percent of individuals aged 18 and over were overweight in 2016, and roughly 13.0 percent of the adult population worldwide was obese. According to the research, nearly 340 million children and adolescents aged 5 to 19 were overweight or obese in 2016.
Regional Insights into the Global Bariatric Surgery Devices Market
Because of the rising prevalence of obesity in the region, North America held the greatest market share in the worldwide bariatric surgery devices market. Obesity was found to be prevalent in 39.8% of adults and 18.5 percent of kids in 2015-2016, according to the Centers for Disease Control and Prevention (CDC). According to research published in the Journal of the American Medical Association in 2018, around 40.0 percent of all adults in the United States, or 93.3 million persons over the age of 20, were obese in 2018.
The Competitive Landscape of the Global Bariatric Surgery Devices Market
Allergan Inc., Cousin Biotech, Covidien PLC, Endogastric Solutions Inc., EntroMedics Inc., GI Dynamics Inc., Intuitive Surgical Inc., Johnson and Johnson, Olympus, Pare Surgical, ReShape Medical, Inc., Spatz FGIA Inc., Transenterix, Inc., and Transenterix, Inc. are key players in the global bariatric surgery devices market.
0 Comments